title: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
abstract: Ischemia often precedes neovascularization. In ocular neovascularization, such as occurs in diabetic retinopathy, a diffusible angiogenic factor has been postulated to be produced by ischemic retina and to lead to neovascularization of the retina, optic nerve, or iris. However, no angiogenic factor has been conclusively identified that satisfies this hypothesis. Vascular endothelial growth factor/vascular permeability factor, hereafter referred to as VEGF, is a likely candidate for an ocular angiogenic factor because it is a secreted mitogen, specific for endothelial cells, and is upregulated by hypoxia. We investigated the association of VEGF with the development of experimental iris neovascularization in the cynomolgus monkey. Following the production of retinal ischemia by laser occlusion of all branch retinal veins, VEGF was increased in the aqueous fluid, and the aqueous VEGF levels changed synchronously and proportionally with the severity of iris neovascularization. Northern analysis and in situ hybridization revealed that VEGF messenger RNA is upregulated in the ischemic retina. These observations support the hypothesis that ocular neovascularization is regulated by a diffusible factor and identify VEGF as a likely candidate for a retina-derived vascular permeability and angiogenesis factor in vivo.
authors.affiliation: Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114.
authors.forename: J W
authors.initials: JW
authors.lastname: Miller
authors.forename: A P
authors.initials: AP
authors.lastname: Adamis
authors.forename: D T
authors.initials: DT
authors.lastname: Shima
authors.forename: P A
authors.initials: PA
authors.lastname: D'Amore
authors.forename: R S
authors.initials: RS
authors.lastname: Moulton
authors.forename: M S
authors.initials: MS
authors.lastname: O'Reilly
authors.forename: J
authors.initials: J
authors.lastname: Folkman
authors.forename: H F
authors.initials: HF
authors.lastname: Dvorak
authors.forename: L F
authors.initials: LF
authors.lastname: Brown
authors.forename: B
authors.initials: B
authors.lastname: Berse
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D016228:Endothelial Growth Factors / Q000378:metabolism*; D005128:Eye Diseases / Q000378:metabolism; D007498:Iris / Q000098:blood supply*; D007511:Ischemia / Q000150:complications / Q000378:metabolism*; D008222:Lymphokines / Q000378:metabolism*; D008252:Macaca fascicularis; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000378:metabolism*; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014822:Vitreous Body / Q000378:metabolism
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors